Is there any role for terlipressin in the extremely low birth weight infant with refractory septic shock?

Francesca Bissolo, Carlo Alberto Forcellini, Stefania Spaggiari, Marcella Gaffuri, Giuseppe Pagano, Paolo Biban

Abstract


Terlipressin, a synthetic long-acting analogue of vasopressin, has been investigated as a second line vasopressor in adults and children with refractory septic shock, i.e. not responding to fluid resuscitation and high-dose catecholamine administration. Little experience is available about the safety and efficacy of terlipressin in term and preterm newborns.

We report the case of an extremely low birth weight infant with severe septic shock, unresponsive to fluids, noradrenalin and hydrocortisone, in whom terlipressin was attempted as a rescue drug. Despite three doses of terlipressin, administered 6-hourly, the patient remained profoundly hypotensive and eventually died.

Further studies are required before any recommendation on the use of terlipressin in term or preterm newborns with septic shock can be made.


Keywords


terlipressin; newborn; ELBW; extremely low birth weight; sepsis; shock

Full Text: PDF Number of abstract views: 3566 Number of PDF views/downloads: 3615

 

N.B. All JPNIM articles are accessible in Open Access. You can access the page containing the full PDF article just by clicking on the “Full Text: PDF” link at the bottom of the abstract page. On the full article page, if the article doesn’t load properly in the PDF view window, please wait a few seconds or click on the “Download this PDF file” link.

Technical advice. If you are using Firefox and you are experiencing problems, please set the browser preferences as follows: Firefox > Preferences > Advanced > General > Accessibility > deselect "Warn me when web sites try to redirect or reload the page".

Privacy Policy. English text: Privacy Policy; Italian text: Privacy Policy.

Cookie Policy. English text: Cookie Policy; Italian text: Cookie Policy.